For Immediate Release
December 19, 2022

Chief Reginald Bellerose Appointed to Carbon RX Board of Directors

Regina, Saskatchewan – Carbon RX Inc. (“Carbon RX”) is pleased to announce the appointment of Chief Reginald Bellerose to the Carbon RX board of directors (“Board of Directors” or “Board”).

Chief Bellerose has been the Chair of Carbon RX’s Council of Advisors offering critical advice and guidance on Carbon RX initiatives in relation to First Nations economic development. Chief Bellerose will continue as chairperson on Carbon RX’s Council of Advisors in addition to his new position as director of Carbon RX.

Chief Bellerose brings his vast experience built over time, previously serving 17 consecutive years as Chief of Muskowekwan First Nations and retiring from this role in July of 2021.

He joins the Board of Directors, alongside fellow directors Lionel Kambeitz, Garth Fredrickson, Wayne Bernakevitch, Jeff Allison, and Marty Seymour.

“I can’t think of a better addition to the Board of Directors,” shares Lionel Kambeitz, Chairman of the Board. “Chief Bellerose is a highly respected leader, with experience advancing impactful First Nations initiatives across Canada. He brings a wealth of knowledge and expertise to the Board and will offer unique perspectives, to ensure First Nations communities have greater participation in the Canadian economy.”

About Carbon RX
Originating in 2006, Carbon RX is a pedigreed and historic North American leader in the origination, validation, digitization and streaming of voluntary Carbon Credits utilizing intellectual property. Carbon RX is again leading the industry in utilizing its proprietary decarbonization and GHG mitigation technologies to originate Carbon Credits and is leveraging digital ledger technology to digitize and add more security and higher value to this asset class.

For media inquiries
Karlee Vorrieter
Cell: 306-537-4590
E‐mail: karlee.vorrieter@carbonrx.com

Forward Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, which is based on Carbon RX’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. All statements other than statements of historical fact are forward-looking information. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “might”, “will”, “shall”, “should”, “intend”, “anticipate”, “project”, “contemplate”, “continue”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. No assurance can be given that these expectations will prove to be correct and such forward-looking information included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. Carbon RX does not undertake any obligations to publicly update or revise any forward-looking information except as required by securities law.

The CSE does not accept responsibility for the adequacy or accuracy of this release.